KOR  ENG

앱클론 로고

Contact

NEST PLATFORM

Different Epitope Different Effect

The activation effect of antibodies differs depending on the binding site of the disease-causing protein.

  • 코끼리 비유
  • Antibodies may have different therapeutic effects depending on which site they bind
    to on the diseased protein. NEST (Novel Epitope Screening Technology) is a discovery
    platform for antibody treatments that bind to a unique site (epitope) of a disease protein,
    and shows a contrasting effect compared to existing antibody treatments. These unique
    antibodies developed through NEST also have shown strong synergy effect when used in
    combination with existing, commercialized antibody treatments.

Pipeline derived from NEST platform

  • AC101
  • Monoclonal antibody treatment for HER2-positive breast and gastric cancer.
Designed by CHAIRONE
  • 앱클론 로고
  • AbClon Inc. #1401 285, Digital-ro, Guro-gu, Seoul, Republic of Korea
    T. +82-2109-1294
    F. +82-2109-1296
    E. abclon@abclon.com
About us
Overview CAR-T GMP History Collaboration Contact Us
Technology
CAR-T platform NEST platform AffiMab platform
Pipeline
AT101 AT501 AC101 AM201 AM105 AM109
Antibody Service
Antibody Service
IR/PR
News Stock IR Information
© AbClon. All rights reserved.